[Multimodal therapy for advanced pancreatic cancer].
Sumii
Toshihiko
T
Department of Gastroenterology, National Kyushu Cancer Center.
Funakoshi
Akihiro
A
Iguchi
Harou
H
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods; D011879:Radiotherapy Dosage; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D000093542:Gemcitabine